Metabolic Testing Market: By Equipment Type Systems, ECG Systems, Metabolic Carts, Others), By Application, By End User and Geography
Metabolic Testing Market size was valued at US$ 541.3 million in 2023 and is poised to grow at a significant CAGR of 7.6% from 2024-2030. Metabolic tests determine how quickly the patient's body burns calories, and these also measure the amount of oxygen used during rest and physical activity. Several years ago, metabolic testing could only be performed in an expensive hospital or laboratory setting. Nowadays, gyms and health clubs are giving metabolic assessments utilizing low-cost equipment.
The processes and equipment used in a gym or health spa setting are frequently like the protocols and equipment used in a hospital setting. Based on the application type, the market is segmented into Critical Care, Lifestyle Diseases. The lifestyle Diseases segment is anticipated to grow at a significant CAGR over the forecast years owing to increased lifestyle disorders such as atherosclerosis, heart disease, obesity, and type 2 diabetes, as well as smoking cessation aids and alcohol use. Lifestyle and nutritional habits have distinct implications on cardiometabolic disease and other metabolic disorders.
According to the World Health Organization (WHO), at least 2.8 million people die each year due to obesity, and nearly 17 million people die each year from cardiovascular diseases. The increased prevalence of lifestyle disorders such as cardiovascular disease, diabetes, and obesity are the primary drivers for the analyzed industry. The rising frequency of lifestyle-related diseases and an aging population predisposed to chronic diseases such as cancer and renal problems are some of the primary reasons driving the market. Furthermore, technical improvements such as introducing digital metabolic rate testing equipment and fast-rising healthcare spending levels will likely drive market expansion throughout the projection period.
In March 2022, to quantify the direct impact of dietary choices on metabolism, Lumen created a platform that enables users to log and track the nutritional value and macronutrients of each item (volumes of fats, carbs, and protein) each meal
Study Period
2024-2030Base Year
2023CAGR
7.6%Largest Market
North AmericaFastest Growing Market
Asia-Pacific
Being overweight is mainly caused by an increase in rapid social life and an unhealthy lifestyle, which drives the expansion of the metabolic testing market. Consumption of snacks, fat-containing meals, and rising disposable income contribute to market expansion.
According to WHO, this contributes to lifestyle diseases such as cancer and chronic diseases. Cancer is the world's second most significant cause of mortality, accounting for an estimated 9.6 million deaths in 2018. Cancer is responsible for around one in every six deaths worldwide. Cancer kills over 70% of people in low- and middle-income nations.
However, a lack of awareness in other middle-income and low-income countries may hamper market expansion. Despite this, technological innovation, rising hospital service standards, and an expanding population are some of the reasons that may create more potential for market growth in the future.
The Metabolic Testing market in North America is likely to hold the highest revenue share in 2021. The same trend is expected over the forecast period due to improvements in metabolic testing technology and the rising incidence of lifestyle-related disorders such as obesity and diabetes, rising healthcare expenditures, a large patient pool, an increase in the level of life, and increased government support in the region, Asia-Pacific is the fastest expanding region in the worldwide metabolic testing market. Furthermore, the metabolic testing market is expanding & with rising healthcare awareness and improved healthcare infrastructure in emerging markets such as India and China.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 541.3 million |
|
Market CAGR |
7.6% |
|
By Equipment Type |
|
|
By Application |
|
|
By Region |
|
Download Free Sample Report
The global metabolic testing market size was valued at US$ 541.3 million in 2023 and is projected to grow at a significant CAGR of 7.6% from 2024-2030.
Major players in the market include MGC Diagnostics Corporation, COSMED Srl, CORTEX Biophysik GmbH, GE Healthcare (General Electric Company), KORR Medical Technologies, Inc, CareFusion Corporation, Geratherm Medical AG, OSI Systems, Inc, AEI Technologies Inc, Parvo Medics.
Among the equipment type, the Body Composition Analyzers accounts for the highest demand in the global metabolic testing devices in 2020.
North America held the highest share
| 1. Executive Summary |
| 2. Global Metabolic Testing Market Introduction |
| 2.1. Global Metabolic Testing Market Taxonomy |
| 2.2. Global Metabolic Testing Market Definitions |
| 2.2.1. By Equipment Type |
| 2.2.2. By Application |
| 2.2.3. By End User |
| 2.2.4. By Region |
| 3. Global Metabolic Testing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Metabolic Testing Market Dynamic Factors - Impact Analysis |
| 3.6. Global Metabolic Testing Market Competition Landscape |
| 4. Global Metabolic Testing Market Analysis 2018 - 2023 and Forecast, 2024 - 2030 |
| 4.1. Market Analysis,2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Metabolic Testing Market, By Equipment Type, 2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1. Body Composition Analyzers |
| 5.1.1. Market Analysis, 2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Cardiopulmonary Exercise Testing (CPET) Systems |
| 5.2.1. Market Analysis, 2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. ECG Systems |
| 5.3.1. Market Analysis, 2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Metabolic Carts |
| 5.4.1. Market Analysis, 2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. others |
| 5.5.1. Market Analysis, 2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6. Global Metabolic Testing Market Forecast, By Application, 2018 - 2023 and Forecast, 2021 2027 (Revenue, USD Mn) |
| 6.1. Critical Care |
| 6.1.1. Market Analysis, 2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Lifestyle Diseases |
| 6.2.1. Market Analysis, 2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Global Metabolic Testing Market, By End User, 2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.1. Hospitals and Clinics |
| 7.1.1. Market Analysis, 2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Sports Training Centers |
| 7.2.1. Market Analysis, 2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Global Metabolic Testing Market Forecast, By Region, 2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia-Pacific |
| 8.3.1. Market Analysis, 2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America |
| 8.4.1. Market Analysis, 2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Middle East and Africa |
| 8.5.1. Market Analysis, 2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Global Metabolic Testing Market - Opportunity Analysis Index, By Equipment Type, By Application, End User, and Region, 2024 - 2030 |
| 9. North America Metabolic Testing Market Analysis,2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.1. By Equipment Type Analysis 2018 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Body Composition Analyzers |
| 9.1.2. Cardiopulmonary Exercise Testing (CPET) Systems |
| 9.1.3. ECG Systems |
| 9.1.4. Metabolic Carts |
| 9.1.5. Others |
| 9.2. By Application Analysis 2018 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.2.1. Critical Care |
| 9.2.2. Lifestyle Diseases |
| 9.3. By End User Analysis 2018 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Hospitals and Clinics |
| 9.3.2. Sports Training Centers |
| 9.3.3. Others |
| 9.4. Country Analysis 2018 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.4.1. USA |
| 9.4.2. Canada |
| 9.5. North America Metabolic Testing Market - Opportunity Analysis Index, By Equipment Type, By Application, End User, and Country, 2024 - 2030 |
| 9.6. North America Metabolic Testing Market Dynamics Trends |
| 10. Europe Metabolic Testing Market Analysis, 2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 10.1. By Equipment Type Analysis 2018 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Body Composition Analyzers |
| 10.1.2. Cardiopulmonary Exercise Testing (CPET) Systems |
| 10.1.3. ECG Systems |
| 10.1.4. Metabolic Carts |
| 10.1.5. Others |
| 10.2. By Application Analysis 2018 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Critical Care |
| 10.2.2. Lifestyle Diseases |
| 10.3. By End User Analysis 2018 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Hospitals and Clinics |
| 10.3.2. Sports Training Centers |
| 10.3.3. Others |
| 10.4. Country Analysis 2018 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Germany |
| 10.4.2. UK |
| 10.4.3. France |
| 10.4.4. Spain |
| 10.4.5. Italy |
| 10.4.6. Russia |
| 10.4.7. Poland |
| 10.4.8. Rest of Europe |
| 10.5. Europe Metabolic Testing Market - Opportunity Analysis Index, By Equipment Type, By Application, End User, and Country, 2024 - 2030 |
| 10.6. Europe Metabolic Testing Market Dynamics Trends |
| 11. Asia-Pacific Metabolic Testing Market Analysis, 2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 11.1. By Equipment Type Analysis 2018 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Body Composition Analyzers |
| 11.1.2. Cardiopulmonary Exercise Testing (CPET) Systems |
| 11.1.3. ECG Systems |
| 11.1.4. Metabolic Carts |
| 11.1.5. Others |
| 11.2. By Application Analysis 2018 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Critical Care |
| 11.2.2. Lifestyle Diseases |
| 11.3. By End User Analysis 2018 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Hospitals and Clinics |
| 11.3.2. Sports Training Centers |
| 11.3.3. Others |
| 11.4. Country Analysis2018 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Japan |
| 11.4.2. China |
| 11.4.3. India |
| 11.4.4. ASEAN |
| 11.4.5. Australia & New Zealand |
| 11.4.6. Rest of Asia-Pacific |
| 11.5. Asia-Pacific Metabolic Testing Market - Opportunity Analysis Index, By Equipment Type, By Application, End User, and Country, 2024 - 2030 |
| 11.6. Asia-Pacific Metabolic Testing Market Dynamics Trends |
| 12. Latin America Metabolic Testing Market Analysis, 2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 12.1. By Equipment Type Analysis 2018 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Body Composition Analyzers |
| 12.1.2. Cardiopulmonary Exercise Testing (CPET) Systems |
| 12.1.3. ECG Systems |
| 12.1.4. Metabolic Carts |
| 12.1.5. Others |
| 12.2. By Application Analysis 2018 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Critical Care |
| 12.2.2. Lifestyle Diseases |
| 12.3. By End User Analysis 2018 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Hospitals and Clinics |
| 12.3.2. Sports Training Centers |
| 12.3.3. Others |
| 12.4. Country Analysis 2018 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Brazil |
| 12.4.2. Mexico |
| 12.4.3. Argentina |
| 12.4.4. Rest of Latin America |
| 12.5. Latin America Metabolic Testing Market - Opportunity Analysis Index, By Equipment Type, By Application, End User, and Country, 2024 - 2030 |
| 12.6. Latin America Metabolic Testing Market Dynamics Trends |
| 13. Middle East and Africa Metabolic Testing Market Analysis, 2018 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 13.1. By Equipment Type Analysis 2018 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Body Composition Analyzers |
| 13.1.2. Cardiopulmonary Exercise Testing (CPET) Systems |
| 13.1.3. ECG Systems |
| 13.1.4. Metabolic Carts |
| 13.1.5. Others |
| 13.2. By Application Analysis 2018 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.2.1. Critical Care |
| 13.2.2. Lifestyle Diseases |
| 13.3. By End User Analysis 2018 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Hospitals and Clinics |
| 13.3.2. Sports Training Centers |
| 13.3.3. Others |
| 13.4. Country Analysis 2018 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Gulf Cooperation Council (GCC) Countries |
| 13.4.2. Israel |
| 13.4.3. South Africa |
| 13.4.4. Rest of MEA |
| 13.5. MEA Metabolic Testing Market - Opportunity Analysis Index, By Equipment Type, By Application, End User, and Country, 2024 - 2030 |
| 13.6. MEA Metabolic Testing Market Dynamics Trends |
| 14. Competition Landscape |
| 14.1. Strategic Dashboard of Top Market Players |
| 14.2. Company Profiles (Introduction, Financial Analysis, By Application & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 14.2.1. MGC Diagnostics Corporation |
| 14.2.2. COSMED srl |
| 14.2.3. CORTEX Biophysik GmbH |
| 14.2.4. GE Healthcare (General Electric Company) |
| 14.2.5. KORR Medical Technologies, Inc |
| 14.2.6. CareFusion Corporation |
| 14.2.7. Geratherm Medical AG |
| 14.2.8. OSI Systems, Inc |
| 14.2.9. AEI Technologies, Inc |
| 14.2.10. Parvo Medics |
| 15. Research Methodology |
| 16. Key Assumptions and Acronyms |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
